Human growth hormone treatment in prepubertal children with achondroplasia

Giovanna Weber, Chiara Prinster, Marta Meneghel, Fiorella Russo, Stefano Mora, Maria Puzzovio, Maurizia Del Maschio, Giuseppe Chiumello

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We studied the effects of recombinant human growth hormone (GH) treatment in 6 prepubertal children with achondroplasia. The patients' age ranged from 2 11/12 to 8 5/12 years and the GH dose was of 0.1 IU/kg/day subcutaneously. Auxological assessments and bone age determinations were performed 6 months before, at the beginning, and after 6 and 12 months of therapy. The growth velocity increase during the whole year of treatment ranged from 1.1 to 2.6 cm/year in 3 patients while in the others no variation was detected. No side effects were observed during the trial apart from a slight advancement of bone age in two patients. MRI at the cervicomedullary junction and CT scan of the base of the skull did not show any variation of the dimensions of the foramen magnum at the end of the trial compared to baseline. Our study shows that r-hGH can safely increase short-term growth velocity in some but not all prepubertal children with achondroplasia. Our data confirm the individual variability in the response to the GH treatment.

Original languageEnglish
Pages (from-to)396-400
Number of pages5
JournalAmerican Journal of Medical Genetics
Volume61
Issue number4
DOIs
Publication statusPublished - Feb 2 1996

Fingerprint

Achondroplasia
Human Growth Hormone
Growth Hormone
Foramen Magnum
Bone and Bones
Skull Base
Therapeutics
Growth

Keywords

  • achondroplasia
  • growth hormone
  • growth velocity

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Human growth hormone treatment in prepubertal children with achondroplasia. / Weber, Giovanna; Prinster, Chiara; Meneghel, Marta; Russo, Fiorella; Mora, Stefano; Puzzovio, Maria; Maschio, Maurizia Del; Chiumello, Giuseppe.

In: American Journal of Medical Genetics, Vol. 61, No. 4, 02.02.1996, p. 396-400.

Research output: Contribution to journalArticle

Weber, Giovanna ; Prinster, Chiara ; Meneghel, Marta ; Russo, Fiorella ; Mora, Stefano ; Puzzovio, Maria ; Maschio, Maurizia Del ; Chiumello, Giuseppe. / Human growth hormone treatment in prepubertal children with achondroplasia. In: American Journal of Medical Genetics. 1996 ; Vol. 61, No. 4. pp. 396-400.
@article{d70207500229472c86c085dbab04d08c,
title = "Human growth hormone treatment in prepubertal children with achondroplasia",
abstract = "We studied the effects of recombinant human growth hormone (GH) treatment in 6 prepubertal children with achondroplasia. The patients' age ranged from 2 11/12 to 8 5/12 years and the GH dose was of 0.1 IU/kg/day subcutaneously. Auxological assessments and bone age determinations were performed 6 months before, at the beginning, and after 6 and 12 months of therapy. The growth velocity increase during the whole year of treatment ranged from 1.1 to 2.6 cm/year in 3 patients while in the others no variation was detected. No side effects were observed during the trial apart from a slight advancement of bone age in two patients. MRI at the cervicomedullary junction and CT scan of the base of the skull did not show any variation of the dimensions of the foramen magnum at the end of the trial compared to baseline. Our study shows that r-hGH can safely increase short-term growth velocity in some but not all prepubertal children with achondroplasia. Our data confirm the individual variability in the response to the GH treatment.",
keywords = "achondroplasia, growth hormone, growth velocity",
author = "Giovanna Weber and Chiara Prinster and Marta Meneghel and Fiorella Russo and Stefano Mora and Maria Puzzovio and Maschio, {Maurizia Del} and Giuseppe Chiumello",
year = "1996",
month = "2",
day = "2",
doi = "10.1002/(SICI)1096-8628(19960202)61:4<396::AID-AJMG17>3.0.CO;2-N",
language = "English",
volume = "61",
pages = "396--400",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Human growth hormone treatment in prepubertal children with achondroplasia

AU - Weber, Giovanna

AU - Prinster, Chiara

AU - Meneghel, Marta

AU - Russo, Fiorella

AU - Mora, Stefano

AU - Puzzovio, Maria

AU - Maschio, Maurizia Del

AU - Chiumello, Giuseppe

PY - 1996/2/2

Y1 - 1996/2/2

N2 - We studied the effects of recombinant human growth hormone (GH) treatment in 6 prepubertal children with achondroplasia. The patients' age ranged from 2 11/12 to 8 5/12 years and the GH dose was of 0.1 IU/kg/day subcutaneously. Auxological assessments and bone age determinations were performed 6 months before, at the beginning, and after 6 and 12 months of therapy. The growth velocity increase during the whole year of treatment ranged from 1.1 to 2.6 cm/year in 3 patients while in the others no variation was detected. No side effects were observed during the trial apart from a slight advancement of bone age in two patients. MRI at the cervicomedullary junction and CT scan of the base of the skull did not show any variation of the dimensions of the foramen magnum at the end of the trial compared to baseline. Our study shows that r-hGH can safely increase short-term growth velocity in some but not all prepubertal children with achondroplasia. Our data confirm the individual variability in the response to the GH treatment.

AB - We studied the effects of recombinant human growth hormone (GH) treatment in 6 prepubertal children with achondroplasia. The patients' age ranged from 2 11/12 to 8 5/12 years and the GH dose was of 0.1 IU/kg/day subcutaneously. Auxological assessments and bone age determinations were performed 6 months before, at the beginning, and after 6 and 12 months of therapy. The growth velocity increase during the whole year of treatment ranged from 1.1 to 2.6 cm/year in 3 patients while in the others no variation was detected. No side effects were observed during the trial apart from a slight advancement of bone age in two patients. MRI at the cervicomedullary junction and CT scan of the base of the skull did not show any variation of the dimensions of the foramen magnum at the end of the trial compared to baseline. Our study shows that r-hGH can safely increase short-term growth velocity in some but not all prepubertal children with achondroplasia. Our data confirm the individual variability in the response to the GH treatment.

KW - achondroplasia

KW - growth hormone

KW - growth velocity

UR - http://www.scopus.com/inward/record.url?scp=0030020454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030020454&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8628(19960202)61:4<396::AID-AJMG17>3.0.CO;2-N

DO - 10.1002/(SICI)1096-8628(19960202)61:4<396::AID-AJMG17>3.0.CO;2-N

M3 - Article

C2 - 8834055

AN - SCOPUS:0030020454

VL - 61

SP - 396

EP - 400

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 4

ER -